# Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer

> **NCT02867839** · PHASE3 · TERMINATED · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 29 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Oxaliplatin plus S-1
- **DRUG:** S-1 only

## Key facts

- **NCT ID:** NCT02867839
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-04-24
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 29 (ACTUAL)
- **Why stopped:** The number of patients enrolled was much less than expected
- **Last updated:** 2024-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02867839

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02867839, "Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer". Retrieved via AI Analytics 2026-09-24 from https://api.ai-analytics.org/clinical/NCT02867839. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*